GL1X · GenesisL1 explorer

MolNFT v2 · #92879 · protein

4GL9: Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130 intracellular domain

4GL9 · Tyrosine-protein kinase: “Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130…”. X-ray diffraction at 3.9, 2 ligands (IZA, PO4), 15 pockets (best druggability 0.81). MolNFT v2…

3D structure of 4GL9: Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130 intracellular domain (MolNFT v2 / PDB Bank)
3D structure of 4GL9: Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130 intracellular domain (MolNFT v2 / PDB Bank)
PDB
4GL9
Type
protein
Length
1,667 residues
Chains
12
Method
x-ray diffraction
Authors
Kershaw, N.J., Murphy, J.M., Laktyushin, A., Nicola, N.A., Babon, J.J.
Deposited
08/14/12
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
3.9
Source
Mus musculus; SYNTHETIC CONSTRUCT
Molecule
Tyrosine-protein kinase; Interleukin-6 receptor subunit beta; Suppressor of cytokine…
EC
2.7.10.2
UniProt
G5E852, Q00560, O35718
Ligands
IZA, PO4
Pockets
15 · best druggability 0.81

Structure

x-ray diffraction · resolution 3.9 · 7 distinct chains · 33% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, DTyrosine-protein kinase (EC 2.7.10.2)protein28439% helix, 20% strandG5E852
BTyrosine-protein kinase (EC 2.7.10.2)protein28239% helix, 21% strandG5E852
I, K, LInterleukin-6 receptor subunit betaprotein80% helix, 38% strandQ00560
JInterleukin-6 receptor subunit betaprotein90% helix, 33% strandQ00560
ESuppressor of cytokine signaling 3,Suppressor of cytokine signaling 3,Suppressor of cytokine signaling 3,Suppressor of cytokine signaling 3protein12426% helix, 29% strandO35718
FSuppressor of cytokine signaling 3,Suppressor of cytokine signaling 3,Suppressor of cytokine signaling 3,Suppressor of cytokine signaling 3protein12625% helix, 29% strandO35718
G, HSuppressor of cytokine signaling 3,Suppressor of cytokine signaling 3,Suppressor of cytokine signaling 3,Suppressor of cytokine signaling 3protein12526% helix, 29% strandO35718

Ligands and binding sites

  • IZA · 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one · ligand · 4 copies · chains A, B, C, D
  • PO4 · Phosphate ion · ion · chains B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19880.810.8296PO4, IZA
24530.780.8641empty
34450.760.8548IZA
46030.730.8068IZA
54640.700.8057IZA

Interfaces

17 interfaces between chains.

  • A–E · 1026 Ų buried · 18 hydrogen bonds · protein-protein
  • B–H · 1022 Ų buried · 16 hydrogen bonds · protein-protein
  • C–G · 1021 Ų buried · 18 hydrogen bonds · protein-protein
  • D–F · 1021 Ų buried · 17 hydrogen bonds · protein-protein
  • J–F · 854 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (phosphorylation).

Compared structures

  • 4GL9 · Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

Other records of 4GL9

  • 4GL9-2 · MolNFT v1 / PDB · Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and…

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.